CHICAGO--(BUSINESS WIRE)--Drive2Earn, a new feature that allows users to earn money while they are on the move, is now available in Tapestri, an app that pays users for sharing their location data, ...

Tapestri from Mission Bio is a precision genomics platform to support the discovery, development and delivery of precision medicine. The Tapestri platform leverages proprietary droplet microfluidics ...

Tapestri introduced an app in November that pays consumers cash for sharing their anonymized location history. The startup then sells the data to brands. Tapestri founder and chief executive officer ...

Mission Bio’s Tapestri Single Cell Multi-Omics Platform for Exploratory Biomarker Analysis Supports Myeloproliferative Neoplasms (MPNs) Data Presentation at ASH 2025 Mission Bio’s Tapestri® Platform ...

Flagship App Pays Users for Location Data; Unique Compensation Model Drives Global Expansion CHICAGO, April 14, 2022 /PRNewswire/ -- Tapestri Inc., the app that pays users for sharing their anonymous ...

CHICAGO, Nov. 30, 2021 /PRNewswire/ -- Tapestri Inc. today announced the launch of its namesake mobile application that pays users for sharing their anonymous location data and intends to expand to ...

The new Tapestri® v3 chemistry increases the number of cells captured per sample by up to four times compared to the prior chemistry, a notable enhancement. With enhanced cell capture, the Tapestri® ...

Mission Bio has completed a $30 million Series B financing, saying it plans to use the proceeds toward expanding and further developing its single-cell DNA genomics platform Tapestri® for oncology; ...

SOUTH SAN FRANCISCO, Calif., Sept. 15, 2022 /PRNewswire/ -- Mission Bio, Inc., the pioneer in high-throughput single-cell DNA analysis, today announced new data supporting the use of its Tapestri ® ...

Tapestri introduced an app in November that pays consumers cash for sharing their anonymized location history. The startup then sells the data to brands. Tapestri founder and chief executive officer ...

Mission Bio’s Tapestri® Platform and custom assay development platform supported exploratory biomarker analysis for Incyte’s INCA033989 clinical trial for myeloproliferative neoplasms (MPNs), enabling ...